Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Omega 3 fatty acids - Nutraceuticals World

What are you searching for?

Sign in
Research

Omega 3 fatty acids

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Reduced mortality (in heart failure patients)



Source: European Society of Cardiology Meeting, Munich, Germany-September.

Research: Investigators in this study conducted a randomized, controlled trial of chronic heart failure patients from 357 cardiovascular sites in Italy. Patients received either omega 3 PUFAs (polyunsaturated fatty acids) in a capsule once daily (3494 patients) or placebo (3481 patients).

Results: Approximately 950 patients (27%) in the PUFA group died, compared with just over 1000 in the placebo group (29%)-there was relative risk reduction of 9% in the PUFA group. Further, more patients in the placebo group (2053/59%) died or were admitted to the hospital for cardiovascular reasons compared with the PUFA group (1981/57%)-a relative risk reduction of 8% for the PUFA group. In the end, researchers reported that omega 3 PUFAs were responsible for significantly reducing all-cause mortality and visits to the hospital for cardiovascular reasons.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics